Geode Capital Management LLC Grows Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Geode Capital Management LLC increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 3.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,320,576 shares of the company's stock after buying an additional 342,819 shares during the period. Geode Capital Management LLC owned 2.48% of GE HealthCare Technologies worth $882,777,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in GEHC. CoreFirst Bank & Trust purchased a new position in shares of GE HealthCare Technologies during the fourth quarter worth approximately $25,000. Runnymede Capital Advisors Inc. purchased a new position in GE HealthCare Technologies during the 4th quarter worth $28,000. Continuum Advisory LLC raised its position in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after purchasing an additional 168 shares in the last quarter. Bank of Jackson Hole Trust purchased a new stake in shares of GE HealthCare Technologies in the 4th quarter worth $32,000. Finally, OFI Invest Asset Management bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth $34,000. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Down 0.6 %

Shares of GEHC stock traded down $0.35 during trading hours on Monday, reaching $60.16. 3,634,776 shares of the company's stock were exchanged, compared to its average volume of 3,026,917. The stock has a market cap of $27.51 billion, a PE ratio of 13.83, a PEG ratio of 3.19 and a beta of 1.14. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The stock's fifty day moving average price is $85.41 and its two-hundred day moving average price is $85.40. GE HealthCare Technologies Inc. has a 1 year low of $58.04 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.23%. GE HealthCare Technologies's payout ratio is presently 3.23%.

Analyst Ratings Changes

A number of research firms recently weighed in on GEHC. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research note on Friday, February 14th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Citigroup increased their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. Finally, The Goldman Sachs Group raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $97.73.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.